1. Home
  2. CURR vs IMRX Comparison

CURR vs IMRX Comparison

Compare CURR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

SELL

Current Price

$1.88

Market Cap

208.8M

ML Signal

SELL

Logo Immuneering Corporation

IMRX

Immuneering Corporation

SELL

Current Price

$3.38

Market Cap

226.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CURR
IMRX
Founded
2013
2008
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.8M
226.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CURR
IMRX
Price
$1.88
$3.38
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
243.0K
★ 750.4K
Earning Date
12-01-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.75
EPS
★ N/A
N/A
Revenue
★ $46,435,412.00
N/A
Revenue This Year
$12.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.31
$3.31
52 Week High
$5.08
$8.48

Technical Indicators

Market Signals
Indicator
CURR
IMRX
Relative Strength Index (RSI) 36.11 38.30
Support Level $1.43 N/A
Resistance Level $3.50 $4.05
Average True Range (ATR) 0.23 0.24
MACD 0.03 -0.01
Stochastic Oscillator 64.18 5.40

Price Performance

Historical Comparison
CURR
IMRX

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: